{"id":"https://openalex.org/W1491077925","doi":null,"title":"Intercellular transfer of drug resistance.","display_name":"Intercellular transfer of drug resistance.","alternate_titles":[],"publication_year":1991,"publication_date":"1991-02-15","ids":{"openalex":"https://openalex.org/W1491077925","mag":"1491077925","pmid":"https://pubmed.ncbi.nlm.nih.gov/1997161"},"language":"en","primary_location":{"id":"pmid:1997161","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W1491077925"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091681401","display_name":"Oskar S. Frankfurt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O S Frankfurt","raw_affiliation_strings":["Oncology Laboratory, Cedars Medical Center, Miami, Florida 33136"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Laboratory, Cedars Medical Center, Miami, Florida 33136","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108770601","display_name":"DANIEL L. SECKINGER","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Seckinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103686778","display_name":"Everett V. Sugarbaker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E V Sugarbaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0338,"has_fulltext":false,"cited_by_count":36,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8787214,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"51","issue":"4","first_page":"1190","last_page":"1195"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.7426999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.7426999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12187","display_name":"Glutathione Transferases and Polymorphisms","score":0.10740000009536743,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.8930000066757202},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.8100000023841858},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.8330000042915344},{"id":"https://openalex.org/keywords/glutathione","display_name":"glutathione","score":0.925000011920929},{"id":"https://openalex.org/keywords/metabolic-cooperation","display_name":"metabolic cooperation","score":0.5839999914169312},{"id":"https://openalex.org/keywords/cell-junctions","display_name":"cell junctions","score":0.8100000023841858},{"id":"https://openalex.org/keywords/phorbol-ester","display_name":"phorbol ester","score":0.9829999804496765},{"id":"https://openalex.org/keywords/buthionine-sulfoximine","display_name":"buthionine sulfoximine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/a2780-cells","display_name":"A2780 cells","score":0.8539999723434448},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7049999833106995},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.780030369758606},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.6394808292388916},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5799562335014343},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5797840356826782},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.5533374547958374},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.4813747704029083},{"id":"https://openalex.org/C2777476445","wikidata":"https://www.wikidata.org/wiki/Q5002519","display_name":"Buthionine sulfoximine","level":4,"score":0.45653611421585083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42596596479415894},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40051737427711487},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3908458948135376},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.35191747546195984},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.31093358993530273},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3075604736804962},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0575527548789978},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000963","descriptor_name":"Antimetabolites","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002450","descriptor_name":"Cell Communication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002450","descriptor_name":"Cell Communication","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003114","descriptor_name":"Colony-Forming Units Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005978","descriptor_name":"Glutathione","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008717","descriptor_name":"Methionine Sulfoximine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008717","descriptor_name":"Methionine Sulfoximine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013755","descriptor_name":"Tetradecanoylphorbol Acetate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019328","descriptor_name":"Buthionine Sulfoximine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1997161","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1491077925","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1292191866","display_name":"FLOW CYTOMETRIC STUDY OF ANTICANCER DRUG EFFECTS ON DNA","funder_award_id":"R01CA050677","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1499700118","https://openalex.org/W1499822007","https://openalex.org/W1602698284","https://openalex.org/W1876684013","https://openalex.org/W2007931369","https://openalex.org/W2062381728","https://openalex.org/W2138019787","https://openalex.org/W2147671232","https://openalex.org/W2150601688","https://openalex.org/W2152549624","https://openalex.org/W2175134346","https://openalex.org/W2263941651"],"related_works":["https://openalex.org/W2939749651","https://openalex.org/W1989504675","https://openalex.org/W1963572510","https://openalex.org/W2034091653","https://openalex.org/W1977583391","https://openalex.org/W2076970453","https://openalex.org/W2414049271","https://openalex.org/W2153571144","https://openalex.org/W1900543109"],"abstract_inverted_index":{"The":[0,238],"effect":[1],"of":[2,21,71,94,115,129,161,171,182,188,211,219,240,246,255,268,277,284,291],"L-phenylalanine":[3],"mustard":[4],"(L-PAM)":[5],"on":[6],"heterogeneous":[7],"cell":[8,112,263,285],"populations":[9],"containing":[10],"sensitive":[11,54,75,81,133,162,178],"and":[12,34,82,126,200,207,232],"resistant":[13,59,83,124,175],"cells":[14,56,63,67,76,84,125,140,144,153,163,176,204,223,227,243,248],"was":[15,50,99,145,166,191],"evaluated":[16],"by":[17,45,101,168,186,193],"flow":[18],"cytometric":[19],"analysis":[20,187],"DNA":[22,42,48,72,121,130,189],"damage.":[23],"Cell":[24],"cultures":[25],"were":[26,85],"treated":[27],"with":[28,36,58,117,142,198,265,275],"L-PAM":[29,199,231],"for":[30],"1":[31],"h,":[32],"fixed,":[33],"stained":[35],"anti-DNA":[37],"monoclonal":[38],"antibody":[39],"which":[40,104],"detects":[41],"damage":[43,49,73,122,131,190],"induced":[44,167,228,271],"alkylating":[46],"agents.":[47],"significantly":[51,146],"lower":[52],"in":[53,65,74,87,97,123,132,138,151,164,205,234],"A2780":[55,66,139,152],"cocultured":[57,141],"A549":[60,143,208,226,242],"or":[61],"A2780/PAM":[62],"than":[64,148],"grown":[68,86,154],"separately.":[69,155],"Decrease":[70],"did":[77],"not":[78],"occur":[79],"when":[80],"common":[88],"medium":[89],"without":[90],"direct":[91],"contact.":[92],"Transfer":[93],"drug":[95,183,269,281],"resistance":[96,184,229,245,254,270,272],"cocultures":[98,116,165],"prevented":[100,127],"phorbol":[102],"ester":[103,252],"is":[105],"known":[106],"to":[107,177,221,230,249,257,273,293],"inhibit":[108],"metabolic":[109],"cooperation":[110,261,286],"via":[111],"junctions.":[113],"Treatment":[114,197],"buthionine":[118],"sulfoximine":[119],"increased":[120,244],"decrease":[128],"cells.":[134,179],"Glutathione":[135],"(GSH)":[136],"content":[137,150],"higher":[147],"GSH":[149,172,220],"We":[156],"conclude":[157],"that":[158],"decreased":[159],"response":[160,290],"contact":[169],"transfer":[170,181,218],"from":[173,224],"GSH-rich":[174,225],"Intercellular":[180],"demonstrated":[185],"confirmed":[192],"colony":[194],"formation":[195],"assay.":[196],"Adriamycin":[201,233],"killed":[202],"all":[203],"A2780/MDR":[206,247],"cultures.":[209],"Coculture":[210],"these":[212],"lines":[213],"survived":[214],"combination":[215,258,294],"treatment":[216,274],"because":[217],"multidrug-resistant":[222],"a":[235],"single":[236],"cell.":[237],"presence":[239],"2%":[241],"L-PAM.":[250],"Phorbol":[251],"eliminated":[253],"coculture":[256],"treatment.":[259],"Metabolic":[260],"between":[262],"subsets":[264],"different":[266,278],"mechanisms":[267],"drugs":[276],"classes":[279],"(multiclass":[280],"resistance).":[282],"Inhibition":[283],"may":[287],"improve":[288],"the":[289],"tumors":[292],"chemotherapy.":[295]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1491077925","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
